NEW YORK (GenomeWeb News) – The National Institute of Drug Abuse will give $10 million in 2010 to fund deep sequencing studies aimed at identifying SNP variants and structural variants that may affect addiction risk in samples that are known to have drug abuse phenotypes.

NIDA plans to issue up to four grants of as much as $2.5 million per year for five years for research that will explore particular pharmacogenomic regions already identified by genome-wide association studies and other means and which could benefit from deep next-generation sequencing and analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.